drugset / Trial / NCT05005260
Liposomal Bupivacaine Single-Injection Interscalene Block vs. Continuous Interscalene Block for Primary Total Shoulder Arthroplasty
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to assess analgesia efficacy between liposomal bupivacaine single injection interscalene blockade vs. continuous interscalene nerve block for patients undergoing primary total shoulder arthroplasty.
Timeline
- Start
- 2021-10-14
- Primary completion
- 2023-03-18
- Completion
- 2023-03-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 8 ml | Other |
| Comparator | Bupivacaine | Other / unclassified | 25 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | 133 mg | Other |